Clinical Trials Logo

Clinical Trial Summary

Evaluate the safety, pharmacokinetics and efficacy of HEC89736 in patients with Relapsed or Refractory B-cell Hematologic Malignancies

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04865458
Study type Interventional
Source Sunshine Lake Pharma Co., Ltd.
Contact Jiang Yingzhi
Phone +86 13692244184
Email [email protected]
Status Recruiting
Phase Phase 1
Start date April 1, 2021
Completion date April 1, 2024